Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DEVELOPMENT OF NOVEL DDS TARGETING LYSOSOMES
Document Type and Number:
WIPO Patent Application WO/2022/145449
Kind Code:
A1
Abstract:
The present invention provides a hydrolase used in enzyme replacement therapy for a lysosomal storage disease. Provided is a hydrolase that is present in lysosomes and that, when deficient, causes a lysosomal storage disease, the hydrolase including at least one sugar chain having a biantennary sugar chain with a sialic acid at an end.

Inventors:
ITOH KOHJI (JP)
KINOSHITA TAKASHI (JP)
MITANI AI (JP)
Application Number:
PCT/JP2021/048780
Publication Date:
July 07, 2022
Filing Date:
December 28, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV TOKUSHIMA (JP)
FUSHIMI PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K38/47; C12N9/14; A61K38/48; A61P3/00; A61P43/00; C12N9/24; C12N9/64; C12N15/56; C12N15/57
Foreign References:
JP2004502456A2004-01-29
JP2020010662A2020-01-23
Other References:
KOJI ITO, ET AL.: "Development of pharmaceuticals for humans and animals using silkworms.", RESEARCH FOR AGRI-HEALTH TRANSLATIONAL RESEARCH PROJECT, AGRIKNOWLEDGE, JAPAN, 1 March 2016 (2016-03-01), Japan, pages 1 - 386, XP055948103, Retrieved from the Internet [retrieved on 20220802]
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF: